Sequential chemotherapy with dose-dense docetaxel, cisplatin, folinic acid and 5-fluorouracil (TCF-dd) followed by combination of oxaliplatin, folinic acid, 5-fluorouracil and irinotecan (COFFI) in metastatic gastric cancer: results of a phase II trial

被引：0
|
作者：
Matteo Dalla Chiesa
Gianluca Tomasello
Sebastiano Buti
Rodrigo Kraft Rovere
Matteo Brighenti
Silvia Lazzarelli
Gianvito Donati
Rodolfo Passalacqua
机构：
[1] Azienda Ospedaliera di Cremona,Departments of Medical Oncology and Biostatistics
[2] Azienda Istituti Ospitalieri,Medical Oncology Division
来源：
Cancer Chemotherapy and Pharmacology | 2011年 / 67卷
关键词：
Sequential chemotherapy; Irinotecan; Oxaliplatin; Docetaxel; Cisplatin; 5-Fluorouracil; Gastric cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：41 / 48
页数：7
相关论文
共 50 条
  • [1] Sequential chemotherapy with dose-dense docetaxel, cisplatin, folinic acid and 5-fluorouracil (TCF-dd) followed by combination of oxaliplatin, folinic acid, 5-fluorouracil and irinotecan (COFFI) in metastatic gastric cancer: results of a phase II trial
    Dalla Chiesa, Matteo
    Tomasello, Gianluca
    Buti, Sebastiano
    Rovere, Rodrigo Kraft
    Brighenti, Matteo
    Lazzarelli, Silvia
    Donati, Gianvito
    Passalacqua, Rodolfo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (01) : 41 - 48
  • [2] High efficacy of sequential chemotherapy (CT) with dose-dense modified TCF regimen (TCF-DD) followed by CT with oxaliplatin, folinic acid (FA), 5-fluorouracil (5-FU) and irinotecan (COFFI) in metastatic gastric cancer (MGC)
    Dalla Chiesa, M.
    Tomasello, G.
    Buti, S.
    Negri, F.
    Brighenti, M.
    Lazzarelli, S.
    Auzzani, A.
    Curti, A.
    Martinotti, M.
    Passalacqua, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] An alternating regimen of irinotecan/5-fluorouracil/folinic acid and oxaliplatin/5-fluorouracil/folinic acid in metastatic colorectal cancer: A phase II trial
    Ferrari, V
    Valcamonico, F
    Amoroso, V
    Simoncini, E
    Vassalli, L
    Marpicati, P
    Rangoni, G
    Grisanti, S
    Pasinetti, N
    Marini, G
    ONCOLOGY, 2005, 69 (04) : 283 - 289
  • [4] Dose-dense chemotherapy with Docetaxel, Cisplatin, folinic acid and 5-fluorouracil (TCAF DD) in metastatic gastric cancer (MGC): A feasibility study
    Dalla Chiesa, M.
    Tomasello, G.
    Buti, S.
    Negli, F.
    Buononato, M.
    Lazzarelli, S.
    Brighenti, M.
    Passalacqua, R.
    ANNALS OF ONCOLOGY, 2006, 17 : XI53 - XI54
  • [5] A pilot phase II study of chemotherapy with oxaliplatin, folinic acid, 5-fluorouracil and irinotecan in metastatic gastric cancer
    Chiesa, Matteo Dalla
    Buti, Sebastiano
    Tomasello, Gianluca
    Negri, Federica
    Buononato, Massimo
    Brunelli, Antonio
    Lazzarelli, Silvia
    Brighentl, Matteo
    Donati, Gianvito
    Passalacqua, Rodolfo
    TUMORI, 2007, 93 (03) : 244 - 247
  • [6] Randomized phase II study of sequential docetaxel and irinotecan with 5-fluorouracil/folinic acid (leucovorin) in patients with advanced gastric cancer: the GATAC trial
    Gubanski, Michael
    Johnsson, Anders
    Fernebro, Eva
    Kadar, Lianna
    Karlberg, Ingegerd
    Flygare, Petra
    Berglund, Ake
    Glimelius, Bengt
    Lind, Pehr A.
    GASTRIC CANCER, 2010, 13 (03) : 155 - 161
  • [7] Randomized phase II study of sequential docetaxel and irinotecan with 5-fluorouracil/folinic acid (leucovorin) in patients with advanced gastric cancer: the GATAC trial
    Michael Gubanski
    Anders Johnsson
    Eva Fernebro
    Lianna Kadar
    Ingegerd Karlberg
    Petra Flygare
    Åke Berglund
    Bengt Glimelius
    Pehr A. Lind
    Gastric Cancer, 2010, 13 : 155 - 161
  • [8] COMPARISON OF CFF (CISPLATIN, 5-FLUOROURACIL, FOLINIC ACID) AND MODIFIED DCF (DOCETAXEL, CISPLATIN, 5-FLUOROURACIL) REGIMENS IN THE FIRST LINE TREATMENT OF METASTATIC GASTRIC CANCER
    Kos, F. T.
    Uncu, D.
    Ozdemir, N.
    Budakoglu, B.
    Odabas, H.
    Babacan, N.
    Cihan, S.
    Seker, M.
    Oksuzoglu, B.
    Zengin, N.
    ANNALS OF ONCOLOGY, 2010, 21 : 240 - 240
  • [9] Chronotherapy with 5-fluorouracil, oxaliplatin, and folinic acid in colorectal cancer
    Sandor, V
    LANCET, 1997, 350 (9087): : 1325 - 1326
  • [10] A phase II study of 5-fluorouracil and high dose folinic acid in cisplatin refractory metastatic bladder cancer
    Huan, SD
    Aitken, SE
    Stewart, DJ
    ANNALS OF ONCOLOGY, 1995, 6 (08) : 836 - 837
12345